Peter Palese

Active 1974–2025

286
Papers
60,919
Citations
142
h-index
281
i10-index

Citations

Citations per year for Peter Palese1969: 2 citations1974: 4 citations1975: 6 citations1976: 17 citations1977: 28 citations1978: 33 citations1979: 34 citations1980: 62 citations1981: 37 citations1982: 44 citations1983: 71 citations1984: 27 citations1985: 57 citations1986: 57 citations1987: 58 citations1988: 60 citations1989: 77 citations1990: 89 citations1991: 127 citations1992: 104 citations1993: 79 citations1994: 129 citations1995: 103 citations1996: 104 citations1997: 115 citations1998: 142 citations1999: 164 citations2000: 192 citations2001: 262 citations2002: 315 citations2003: 226 citations2004: 384 citations2005: 367 citations2006: 484 citations2007: 459 citations2008: 558 citations2009: 749 citations2010: 723 citations2011: 606 citations2012: 578 citations2013: 766 citations2014: 716 citations2015: 613 citations2016: 609 citations2017: 559 citations2018: 615 citations2019: 1,998 citations2020: 2,248 citations2021: 2,112 citations2022: 1,402 citations2023: 1,012 citations2024: 1,482 citations2025: 657 citations2026: 11 citations1970–1973: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,819 citing papers, 34.8% of this breakdownChina: 1,573 citing papers, 9.4% of this breakdownUnited Kingdom: 1,122 citing papers, 6.7% of this breakdownGermany: 838 citing papers, 5% of this breakdownFrance: 591 citing papers, 3.5% of this breakdownCanada: 561 citing papers, 3.3% of this breakdownJapan: 540 citing papers, 3.2% of this breakdownAustralia: 496 citing papers, 3% of this breakdownNetherlands: 430 citing papers, 2.6% of this breakdownItaly: 310 citing papers, 1.9% of this breakdownIndia: 309 citing papers, 1.8% of this breakdownSpain: 286 citing papers, 1.7% of this breakdown
0%34.8%Other 23.1%

Fields

  • Medicine63%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Immunology and Microbiology12%
  • Agricultural and Biological Sciences3.3%
  • Environmental Science1.4%
  • Mathematics1.2%
  • Other2.8%

Topics

  • Influenza Virus Research Studies13.5%
  • Respiratory viral infections research7%
  • interferon and immune responses4.9%
  • SARS-CoV-2 and COVID-19 Research4.3%
  • Viral gastroenteritis research and epidemiology3.5%
  • Virus-based gene therapy research2.7%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Influenza

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2018 cited by 1,551

  2. The biology of influenza viruses

    Authors: , - Vaccine 2008 cited by 1,207

  3. A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

    Authors: , , , , , , , , , , , , , , - Molecular Therapy 2020 cited by 310

  4. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adolfo García‐Sastre, Peter Palese, Florian Krammer - Nature Medicine 2020 cited by 358

  5. Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature

    Authors: , , , - PLoS Pathogens 2007 cited by 1,719

  6. Broadly neutralizing antibodies target a haemagglutinin anchor epitope

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynda Coughlan, Andrew B. Ward, Patrick C. Wilson - Nature 2021 cited by 190

  7. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kwanyee Leung, Wing‐Pui Kong, Alec W. Freyn, Raffael Nachbagauer, Peter Palese, Robert T. Bailer, Adrian B. McDermott, Richard A. Koup, Jason G. Gall, Frank Arnold, John R. Mascola, Barney S. Graham, Julie E. Ledgerwood, the VRC 316 Study Team, Joseph P. Casazza, LaSonji A. Holman, Abidemi O. Ola, Pamela Costner, Jennifer Cunningham, Brenda Larkin, Laura Novik, Jamie Saunders, William Whalen, Xiaolin Wang, Aba Mensima Eshun, Alison Taylor, K.-C. Cheng, Carolyn M. Laurençot, Josephine H. Cox, Sandra Sitar, Lam Le, Iris Pittman, Olga Vasilenko, Ro Shauna Rothwell, Galina V. Yamshchikov, Eugenia Burch, Somia P. Hickman, Olga Trofymenko, Catina Boyd, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Zana Blaku, Colin Tran - Nature Medicine 2022 cited by 163

  8. Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

    Authors: , , , - Nature Medicine 2014 cited by 771

  9. Advances in the development of influenza virus vaccines

    Authors: , - Nature Reviews Drug Discovery 2015 cited by 601

  10. Immune history profoundly affects broadly protective B cell responses to influenza

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 426

  11. Is a Universal Influenza Virus Vaccine Possible?

    Authors: , - Annual Review of Medicine 2019 cited by 160

  12. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

    Authors: , , , - Journal of Clinical Investigation 2016 cited by 428

  13. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bob C. Lin, Sarah O’Connell, Alec W. Freyn, Victoria Rosado, Raffael Nachbagauer, Peter Palese, Masaru Kanekiyo, Adrian B. McDermott, Richard A. Koup, Lesia Dropulic, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, on behalf of the VRC 321 study team, Allison Beck, Joseph P. Casazza, Christopher L. Case, John Misasi, Abidemi O. Ola, Karen Parker, Richard Wu, Pamela Costner, Jamie Saunders, Laura Novik, William Whalen, Xiaolin Wang, Aba Mensima Eshun, Jennifer Cunningham, Anita Arthur, Morgan Anderson, Justine Jones, Brenda Larkin, Thuy Nguyen, Sandra Sitar, Lam Le, Iris Pittman, Olga Vasilenko, Galina V. Yamshchikov, Ro Shauna Rothwell, Eugenia Burch, Olga Trofymenko, Sarah H. Plummer, Catina Evans, Cora Trelles Cartagena, Renunda Hicks, LaShawn Requilman, Pernell Williams, Carmencita Graves, Shinyi Telscher, Gabriela Albright, Jessica Bahorich, Sashikanth Banappagari, Michael Bender, Alegria T. Caringal, Juliane Guimarães de Carvalho, Rajoshi Chaudhuri, Mythili Chintamani, Jonathan W. Cooper, Jacob Demirji, Tracey Dinh, G Dobrescu, Alvenne Goh, Deepika Gollapudi, Raju Gottumukkala, Daniel B. Gowetski, Janel Holland-Linn, Jin Hong, Joe Horwitz, Vera B. Ivleva, Lisa A. Kueltzo and 26 more - Science Translational Medicine 2023 cited by 96

  14. Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

    Authors: , , , , , , , - Virology 1998 cited by 1,008

  15. Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N

    Authors: , , , - PLoS Pathogens 2009 cited by 589

  16. Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

    Authors: , , , , , , , , , - Cell 2015 cited by 214

  17. Cross-neutralization of influenza A viruses mediated by a single antibody loop

    Authors: , , , , , , , , , , , , , , , , , - Nature 2012 cited by 502

  18. Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

    Authors: , , , , , , , , - Science Translational Medicine 2014 cited by 704

  19. A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission

    Authors: , , , , , , , , , , - Science 2007 cited by 582

  20. A novel influenza A virus mitochondrial protein that induces cell death

    Authors: , , , , , , , , , , , , - Nature Medicine 2001 cited by 1,041

  21. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 245

  22. Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice

    Authors: , , , , , , , , - mBio 2015 cited by 237

  23. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 187

  24. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

    Authors: , , , , , , , , , , , , , - Nature Immunology 2017 cited by 185